BR0004066A - Composto ou um éster ou sal deste farmaceuticamente aceitáveis, uso do mesmo, composição farmacêutica, e, composto ou um derivado de acetal deste - Google Patents
Composto ou um éster ou sal deste farmaceuticamente aceitáveis, uso do mesmo, composição farmacêutica, e, composto ou um derivado de acetal desteInfo
- Publication number
- BR0004066A BR0004066A BR0004066-5A BR0004066A BR0004066A BR 0004066 A BR0004066 A BR 0004066A BR 0004066 A BR0004066 A BR 0004066A BR 0004066 A BR0004066 A BR 0004066A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- pharmaceutically acceptable
- salt
- pharmaceutical composition
- acetal derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/56—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and doubly-bound oxygen atoms bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
"COMPOSTO OU UM éSTER OU SAL DESTE FARMACEUTICAMENTE ACEITáVEIS, USO DO MESMO, COMPOSIçãO FARMACêUTICA, E, COMPOSTO OU UM DERIVADO DE ACETAL DESTE". Compostos da seguinte fórmula (I) e seus sais e derivados de éster farmaceuticamente aceitáveis: em que Ar é um grupo fenila que pode ser opcionalmente substituído por 1 a 3 substituintes selecionados do grupo que consiste de átomos halógenos e de grupos trifluorometila, têm excelente atividade anti-fúngica.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP25570299 | 1999-09-09 | ||
JP2000103826 | 2000-04-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0004066A true BR0004066A (pt) | 2001-04-17 |
Family
ID=26542380
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0004066-5A BR0004066A (pt) | 1999-09-09 | 2000-09-08 | Composto ou um éster ou sal deste farmaceuticamente aceitáveis, uso do mesmo, composição farmacêutica, e, composto ou um derivado de acetal deste |
Country Status (23)
Country | Link |
---|---|
US (3) | US6391903B1 (pt) |
EP (1) | EP1083175B1 (pt) |
KR (1) | KR100592201B1 (pt) |
CN (1) | CN1167700C (pt) |
AR (1) | AR025610A1 (pt) |
AT (1) | ATE244238T1 (pt) |
AU (1) | AU778073B2 (pt) |
BR (1) | BR0004066A (pt) |
CA (1) | CA2317691C (pt) |
DE (1) | DE60003618T2 (pt) |
DK (1) | DK1083175T3 (pt) |
ES (1) | ES2200786T3 (pt) |
HK (1) | HK1034259A1 (pt) |
HU (1) | HU224699B1 (pt) |
ID (1) | ID27234A (pt) |
IL (1) | IL138329A0 (pt) |
NO (1) | NO318352B1 (pt) |
NZ (1) | NZ506818A (pt) |
PT (1) | PT1083175E (pt) |
RU (1) | RU2203280C2 (pt) |
SA (1) | SA00210602B1 (pt) |
TR (1) | TR200002610A3 (pt) |
TW (1) | TW530057B (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI334866B (en) | 2002-05-29 | 2010-12-21 | Mercian Corp | Novel physiologically active substances |
WO2004108134A1 (ja) * | 2003-06-06 | 2004-12-16 | Sankyo Company, Limited | トリアゾール化合物を含有する医薬組成物 |
KR101191682B1 (ko) * | 2005-12-01 | 2012-10-16 | 바실리어 파마슈티카 아게 | 에폭시부탄올 중간체의 제조 방법 |
EP2116542A4 (en) | 2007-01-29 | 2011-05-04 | Eisai R&D Man Co Ltd | SOLID OF A MAKROLIDE COMPOUND, METHOD OF MANUFACTURING THEREOF AND PHARMACEUTICAL COMPOSITION THEREWITH |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8322983D0 (en) * | 1983-08-26 | 1983-09-28 | Pfizer Ltd | Triazole antifungal agents |
US4483863A (en) * | 1984-01-20 | 1984-11-20 | Pfizer Inc. | Triazole antifungal agents |
GB9002375D0 (en) * | 1990-02-02 | 1990-04-04 | Pfizer Ltd | Triazole antifungal agents |
CA2049802A1 (en) * | 1990-08-26 | 1992-02-27 | Sadao Oida | Anti-fungal triazole derivatives, their preparation and uses |
HU227320B1 (en) | 1995-04-06 | 2011-03-28 | Daiichi Sankyo Co Ltd | 1,2,4-triazole-derivatives, fungicide compositions containing these compounds as active ingredients |
JP2902345B2 (ja) | 1995-04-06 | 1999-06-07 | 三共株式会社 | トリアゾール抗真菌剤 |
EP0780380B1 (en) * | 1995-12-22 | 2001-06-13 | Ss Pharmaceutical Co., Ltd. | Triazole derivatives with antimycotic action and intermediates |
JP3622882B2 (ja) | 1996-10-04 | 2005-02-23 | 三共株式会社 | トリアゾール誘導体を含有する医薬 |
AU5779598A (en) | 1997-02-04 | 1998-08-25 | Sankyo Company Limited | Triazole derivatives |
AU7937998A (en) | 1997-07-08 | 1999-02-08 | Sankyo Company Limited | Antifungal triazole compounds |
US6303728B1 (en) | 1997-07-08 | 2001-10-16 | Kaneka Corporation | Hydrosilylation process and polymers produced by the process |
JPH1180135A (ja) | 1997-07-08 | 1999-03-26 | Sankyo Co Ltd | 抗真菌トリアゾール化合物 |
-
2000
- 2000-09-06 US US09/656,154 patent/US6391903B1/en not_active Expired - Fee Related
- 2000-09-07 IL IL13832900A patent/IL138329A0/xx not_active IP Right Cessation
- 2000-09-07 TW TW089118332A patent/TW530057B/zh not_active IP Right Cessation
- 2000-09-07 NZ NZ506818A patent/NZ506818A/en not_active IP Right Cessation
- 2000-09-07 CA CA002317691A patent/CA2317691C/en not_active Expired - Fee Related
- 2000-09-08 KR KR1020000053581A patent/KR100592201B1/ko not_active IP Right Cessation
- 2000-09-08 AT AT00307799T patent/ATE244238T1/de active
- 2000-09-08 ES ES00307799T patent/ES2200786T3/es not_active Expired - Lifetime
- 2000-09-08 AU AU56575/00A patent/AU778073B2/en not_active Ceased
- 2000-09-08 EP EP00307799A patent/EP1083175B1/en not_active Expired - Lifetime
- 2000-09-08 BR BR0004066-5A patent/BR0004066A/pt not_active Application Discontinuation
- 2000-09-08 DK DK00307799T patent/DK1083175T3/da active
- 2000-09-08 PT PT00307799T patent/PT1083175E/pt unknown
- 2000-09-08 ID IDP20000767D patent/ID27234A/id unknown
- 2000-09-08 NO NO20004511A patent/NO318352B1/no not_active IP Right Cessation
- 2000-09-08 DE DE60003618T patent/DE60003618T2/de not_active Expired - Lifetime
- 2000-09-08 HU HU0003555A patent/HU224699B1/hu not_active IP Right Cessation
- 2000-09-08 AR ARP000104723A patent/AR025610A1/es not_active Application Discontinuation
- 2000-09-08 RU RU2000123391/14A patent/RU2203280C2/ru not_active IP Right Cessation
- 2000-09-08 TR TR2000/02610A patent/TR200002610A3/tr unknown
- 2000-09-09 CN CNB001331442A patent/CN1167700C/zh not_active Expired - Fee Related
- 2000-12-11 SA SA00210602A patent/SA00210602B1/ar unknown
-
2001
- 2001-06-01 US US09/872,744 patent/US6337403B1/en not_active Expired - Fee Related
- 2001-07-17 HK HK01104993A patent/HK1034259A1/xx not_active IP Right Cessation
- 2001-07-18 US US09/907,857 patent/US6392082B1/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0015203B8 (pt) | derivado de quinazolina, composição farmacêutica, e, uso de um composto | |
PT1119567E (pt) | Derivados de quinazolina | |
BR9913903A (pt) | Composto, método para tratar ou impedir um estado doentio, e, composição farmacêutica | |
ATE174899T1 (de) | Zytotoxische stilben-derivate und diese enthaltende pharmazeutische zusammensetzungen | |
BR0112484A (pt) | Composto ou um seu sal, éster ou outro derivado farmacologicamente aceitável, composição farmacêutica, uso de um composto ou de um seu sal, éster ou outro derivado farmacologicamente aceitável, e, processo para a preparação do mesmo | |
DK0880508T3 (da) | Quinazolinderivater som VEGF-inhibitorer | |
CA2263319A1 (en) | Quinazoline derivatives and pharmaceutical compositions containing them | |
BR0014133A (pt) | Uso de um composto, composto, métodos de preparação de um composto, e para inibir aurora 2 quinase em um animal de sangue quente, e, composição farmacêutica | |
BR9806413A (pt) | Composto e uso do mesmo | |
BR0012646A (pt) | Composto, análogo de oligonucleotìdeo ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de um análogo de oligonucleotìdeo | |
FR2676444B1 (fr) | Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant. | |
PT1157998E (pt) | Compostos heterociclicos seus intermediarios e inibidores da elastase | |
TR200000153T2 (tr) | İl-5 inhibite eden 6-azaurasil türevleri. | |
BR0115454A (pt) | Composto de 1-metilcarbapenem ou um sal ou derivado de éster deste farmaceuticamente aceitável, composição farmacêutica, e, uso de um composto ou de um sal ou derivado de éster deste farmaceuticamente aceitável | |
BR0004066A (pt) | Composto ou um éster ou sal deste farmaceuticamente aceitáveis, uso do mesmo, composição farmacêutica, e, composto ou um derivado de acetal deste | |
KR890017252A (ko) | 티에노트리아졸로디아제핀 화합물 및 그의 약학적 용도 | |
BRPI9911178B8 (pt) | derivados de 3-(2-oxo-[1,3']bipirrolidinil-3-ilidenometil)-cefems, bem como preparação farmacêutica e uso dos mesmos | |
FI842081A0 (fi) | Tetrahydroisoxazolo/4,5- c/pyridinderivat samt farmaceutiska kompositioner. | |
EA200600022A1 (ru) | Применение производных бицикло [2.2.1] гептана для приготовления нейропротекторных фармацевтических композиций | |
IL40050A (en) | Compositions for treating microbial infections containing piperidine derivatives | |
BR0109573A (pt) | Composto ou uma pró-droga ou um sal farmacologicamente aceitável do mesmo, agente, composição farmacêutica, e, uso de um composto ou uma pró-droga ou um sal farmacologicamente aceitável do mesmo | |
DE69528984T2 (de) | Hemmung der leukotrienbiosynthese mittels harnstoffderivaten | |
KR920701163A (ko) | 퀴놀론 카르복실산 유도체 | |
BR9807703A (pt) | Derivados de 4-aminoalcóxi-1,3-diidrobenzoimidazol-2-ona, suas preparações e seus usos como agonistas (d2) auto-receptores da dopamina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |